Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | PPCB | VRAX | ||
| Company | Phasebio Pharmaceuticals Inc | Propanc Biopharma Inc | Virax Biolabs Group Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0800 | 1.6200 | 4.01 | ||
| High | 0.0920 | 1.6700 | 4.16 | ||
| Low | 0.0665 | 1.5600 | 3.57 | ||
| Latest | 0.0701 | 1.6300 | 3.74 | ||
| Change | -0.0249 | +0.0300 | -0.33 | ||
| % Change | -26.21% | +1.87% | -8.11% | ||
| Volume | 9,647,400 | 93,600 | 247,500 | ||
| 20-Day Average Volume | 3,930,150 | 3,148,680 | 3,929,304 | ||
| Previous Close | 0.0950 | 1.6000 | 4.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 1.6545 | 3.71 | ||
| 20-Day Raw Stochastic | 2.27% | 24.90% | 11.02% | ||
| 20-Day Relative Strength | 20.88 | 45.04 | 48.03 | ||
| Weighted Alpha | -91.26 | -96.69 | -87.97 | ||
| Today's Opinion | 100% Sell | 100% Sell | 80% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 80% Sell | ||
| Last Month's Opinion | 72% Sell | 64% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | -10.44% since 07/07/26 | +23.03% since 07/07/26 | ||
| Low | 0.0665 on 11/02/22 | 1.5600 on 07/14/26 | 2.92 on 07/08/26 | ||
| High | 0.1440 on 10/27/22 | 1.8999 on 07/09/26 | 13.19 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -28.19% since 06/12/26 | -18.70% since 06/12/26 | ||
| Low | 0.0665 on 11/02/22 | 1.3515 on 06/23/26 | 2.57 on 07/01/26 | ||
| High | 0.2250 on 10/14/22 | 2.4700 on 07/02/26 | 13.19 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -33.13% since 04/14/26 | +1.08% since 04/14/26 | ||
| Low | 0.0665 on 11/02/22 | 1.3000 on 06/10/26 | 2.57 on 07/01/26 | ||
| High | 1.3800 on 08/09/22 | 6.7900 on 06/11/26 | 13.34 on 05/18/26 | ||
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | -84.62% since 01/14/26 | -55.10% since 01/14/26 | ||
| Low | 0.0665 on 11/02/22 | 1.3000 on 06/10/26 | 2.50 on 04/10/26 | ||
| High | 1.3800 on 08/09/22 | 10.9500 on 01/15/26 | 13.34 on 05/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 3,645 | 3,244 | ||
| Shares Outstanding, K | 49,858 | 2,278 | 797 | ||
| Annual Sales | 10,830,000 | 0 | 10,000 | ||
| Annual Net Income | -131,070,000 | -58,920,000 | -5,020,000 | ||
| Last Quarter Sales | 210,000 | 0 | N/A | ||
| Last Quarter Net Income | -16,670,000 | -6,360,000 | N/A | ||
| 60-Month Beta | 2.57 | 3.49 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | -7.00 on 05/14/26 | N/A | ||
| Earnings Date | 11/09/22 | 10/05/26 | 10/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||